uc003mhh.2

GCCCAGCACTCTCAGTGGGGAGCCAGGTGGGAGAACAGGCTCGGAAGGGGACCTAGGCTTATGCAGCGAGCCGGGCAAAGCTGGAACTGGAGCCCAGGCCCCTGGATGCCCCCTGGCTTGTGGAGTTCTGGGATACTGAGGGGAGGGGACAGGGCATGGGAGTGCGGTGCTCTCACCTTTGACTTGAACTCATTCCCCAGGGGACAGGGGAGGCCTCCTCAGGATCCACAGATGCCCAGTCTCCCAAGAG
...........................................................................................................................................((((((((..((((.((.(((((.((...)).))).))..)).))))..)))..)))))....................................................
.........................................................................................................................................138...........................................................200................................................

Size

Perfect hit

Total Norm

Perfect Norm

SRR189783

SRR189782

SRR387910(GSM843862)
antibody for ip: Ago2. (ago2 cell line)

DRR000558(DRX000316)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)

SRR060981(GSM569185)
Human centroblast [09-001]. (cell line)

SRR189784

SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)

SRR039191(GSM494810)
PBMCs were isolated by ficoll gradient from t. (blood)

SRR033725(GSM497070)
Unmutated CLL (CLLU626). (B cell)

DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)

SRR060983(GSM569187)
Human pre-germinal center B cell [09-001]. (cell line)

SRR207110(GSM721072)
Nuclear RNA. (cell line)

DRR000561(DRX000319)
Isolation of RNA following immunoprecipitatio. (ago2 cell line)

SRR037941(GSM510479)
293DroshaTN. (cell line)

SRR033718(GSM497063)
Multiple Myeloma (U266). (B cell)

TAX577579(Rovira)
total RNA. (breast)

SRR060982(GSM569186)
Human centrocyte [09-001]. (cell line)

RoviraIPAgo2(Rovira)
total RNA. (ago2 breast)

DRR000555(DRX000313)
"THP-1 whole cell RNA, no treatment". (cell line)

SRR060984(GSM569188)
Human plasma cell [09-001]. (cell line)

SRR039620(GSM531983)
HBV(+) Adjacent Tissue Sample 2. (liver)

SRR015360(GSM380325)
Plasma B cells (PC137). (B cell)

SRR107297(GSM677704)
18-30nt fraction of small RNA. (cell line)

GSM1105750AGO3(GSM1105750)
small RNA sequencing data. (ago3 hela)

SRR444057(SRX128905)
Sample 15cDNABarcode: AF-PP-334: ACG CTC TTC . (skin)

SRR330858(SRX091696)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330866(SRX091704)
tissue: skin psoriatic involveddisease state:. (skin)

DRR000557(DRX000315)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)

TAX577588(Rovira)
total RNA. (breast)

SRR039193(GSM494812)
HL60 cell line is derived from acute promyelo. (cell line)

SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)

SRR033720(GSM497065)
EBV activated B cell line (EBV159). (B cell)

SRR444058(SRX128906)
Sample 16cDNABarcode: AF-PP-335: ACG CTC TTC . (skin)

DRR000562(DRX000320)
Isolation of RNA following immunoprecipitatio. (ago3 cell line)

SRR039635(GSM518472)
THP1_nuc_sRNAs. (cell line)

SRR330921(SRX091759)
tissue: normal skindisease state: normal. (skin)

SRR039615(GSM531978)
Severe Chronic Hepatitis B Liver Tissue. (liver)

SRR039625(GSM531988)
HBV(-) HCV(-) HCC Tissue Sample. (liver)

TAX577741(Rovira)
total RNA. (breast)

SRR342896(SRX096792)
small RNA seq of Right atrial tissue. (heart)

SRR033719(GSM497064)
6hr Activated B cell line (ABC158). (B cell)

SRR330865(SRX091703)
tissue: skin psoriatic involveddisease state:. (skin)

SRR330915(SRX091753)
tissue: normal skindisease state: normal. (skin)

SRR330916(SRX091754)
tissue: normal skindisease state: normal. (skin)

SRR191407(GSM715517)
81genomic small RNA (size selected RNA from t. (breast)

SRR326282(GSM769512)
"Dicer mRNA was knocked down using siDicer, t. (cell line)

DRR000559(DRX000317)
"THP-1 whole cell RNA, no treatment". (cell line)

SRR060985(GSM569189)
Human naive B cell [09-001]. (cell line)

SRR039623(GSM531986)
HCV(+) HCC Tissue Sample. (liver)

GSM450606(GSM450606)
miRNA sequencing raw reads from post-mortem s. (brain)

SRR330895(SRX091733)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR330905(SRX091743)
tissue: normal skindisease state: normal. (skin)

GSM1105748AGO1(GSM1105748)
small RNA sequencing data. (ago1 hela)

SRR191613(GSM715723)
66genomic small RNA (size selected RNA from t. (breast)

GSM1105749AGO2(GSM1105749)
small RNA sequencing data. (ago2 hela)

SRR033713(GSM497058)
Burkitt Lymphoma (BL115). (B cell)

SRR037936(GSM510474)
293cand1. (cell line)

SRR553575(SRX182781)
source: Kidney. (Kidney)

SRR330859(SRX091697)
tissue: skin psoriatic involveddisease state:. (skin)

SRR553576(SRX182782)
source: Testis. (testes)

SRR330873(SRX091711)
tissue: skin psoriatic involveddisease state:. (skin)

SRR207111(GSM721073)
Whole cell RNA. (cell line)

SRR363673(GSM830250)
cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)

SRR189787

SRR342897(SRX096793)
small RNA seq of Left atrial tissue. (heart)

SRR330908(SRX091746)
tissue: normal skindisease state: normal. (skin)

GSM450604(GSM450604)
miRNA sequencing raw reads from post-mortem s. (brain)

SRR553573(SRX182779)
source: Cerebellum. (Cerebellum)

SRR330899(SRX091737)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR330902(SRX091740)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR330872(SRX091710)
tissue: skin psoriatic involveddisease state:. (skin)

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCCAGT.................................................

42.00

14.00

4.00

1.00

2.00

4.00

1.00

2.00

3.00

2.00

1.00

2.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGT.................................................

16.00

10.00

1.00

4.00

1.00

14.00

2.00

3.00

1.00

2.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAG..................................................

10.00

7.00

3.00

.....................................................................................................................................................................................................CAGGGGACAGGGGAGGGCTA.................................

8.00

0.00

3.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGA.................................................

8.00

10.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGAA................................................

5.00

10.00

2.00

1.00

2.00

5.00

14.00

1.00

.....................................................................................................................................................................................................CAGGGGACAGGGGAGGGC...................................

4.00

0.00

1.00

..............................GAGAACAGGCTCGGAAG...........................................................................................................................................................................................................

4.00

......................................GCTCGGAAGGGGACCTAGGCTTATGCA.........................................................................................................................................................................................

3.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGTA................................................

2.00

10.00

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCCAT..................................................

2.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGG.................................................

2.00

1.00

............................................................................................................................................................................TCACCTTTGACTTGATCC............................................................

2.00

0.00

2.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAA..................................................

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAAG.................................................

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCA...................................................

1.00

.....................................................................................................................................................................................................CAGGGGACAGGGGAGGCCTA.................................

1.00

0.00

1.00

..................................................................................................................................................................TGCGGTGCTCTCACCGCCG.....................................................................

1.00

0.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGAGT...............................................

1.00

10.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCC....................................................

1.00

...................................................................................................................GCTTGTGGAGTTCTGCGG.....................................................................................................................

1.00

0.00

1.00

.................................................................................................................................................................GTGCGGTGCTCTCACATTA......................................................................

1.00

0.00

1.00

14.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAAT.................................................

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCCA...................................................

1.00

.........................................................................................................................................GAGGGGAGGGGACAGGGCAGGGG..........................................................................................

1.00

0.00

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCC....................................................

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAGTAG...............................................

1.00

10.00

1.00

..........................................................................................................................................AGGGGAGGGGACAGGGCATGGG..........................................................................................

1.00

.................................................................................................................................................GGGACAGGGCATGGGAGGCAG....................................................................................

1.00

0.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCAT..................................................

1.00

...................................................................................................................................................................................TGACTTGAACTCATTCCCCAGAGAA..............................................

1.00

0.00

1.00

..................................................................................................................................................................................TTGACTTGAACTCATTCCCCATT.................................................

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCCAA..................................................

1.00

14.00

1.00

14.00

1.00

.................................................................................................................................................................................TTTGACTTGAACTCATTCCCTAA..................................................

1.00

0.00

1.00

.....................................................................................................................................................................................................CAGGGGACAGGGGAGGC....................................

0.67

0.50

0.17

GCCCAGCACTCTCAGTGGGGAGCCAGGTGGGAGAACAGGCTCGGAAGGGGACCTAGGCTTATGCAGCGAGCCGGGCAAAGCTGGAACTGGAGCCCAGGCCCCTGGATGCCCCCTGGCTTGTGGAGTTCTGGGATACTGAGGGGAGGGGACAGGGCATGGGAGTGCGGTGCTCTCACCTTTGACTTGAACTCATTCCCCAGGGGACAGGGGAGGCCTCCTCAGGATCCACAGATGCCCAGTCTCCCAAGAG ...........................................................................................................................................((((((((..((((.((.(((((.((...)).))).))..)).))))..)))..))))).................................................... .........................................................................................................................................138...........................................................200................................................	Size	Total Norm	SRR189783	SRR189782	SRR387910(GSM843862) antibody for ip: Ago2. (ago2 cell line)	DRR000558(DRX000316) "THP-1 whole cell RNA, after 3 day treatment . (cell line)	SRR060981(GSM569185) Human centroblast [09-001]. (cell line)	SRR189784	SRR207115(GSM721077) XRN1&2 knockdown. (XRN1/XRN2 cell line)	SRR039191(GSM494810) PBMCs were isolated by ficoll gradient from t. (blood)	SRR033725(GSM497070) Unmutated CLL (CLLU626). (B cell)	DRR000556(DRX000314) "THP-1 whole cell RNA, after 3 day treatment . (cell line)	SRR060983(GSM569187) Human pre-germinal center B cell [09-001]. (cell line)	SRR207110(GSM721072) Nuclear RNA. (cell line)	DRR000561(DRX000319) Isolation of RNA following immunoprecipitatio. (ago2 cell line)	SRR037941(GSM510479) 293DroshaTN. (cell line)	SRR033718(GSM497063) Multiple Myeloma (U266). (B cell)	TAX577579(Rovira) total RNA. (breast)	SRR060982(GSM569186) Human centrocyte [09-001]. (cell line)	RoviraIPAgo2(Rovira) total RNA. (ago2 breast)	DRR000555(DRX000313) "THP-1 whole cell RNA, no treatment". (cell line)	SRR060984(GSM569188) Human plasma cell [09-001]. (cell line)	SRR039620(GSM531983) HBV(+) Adjacent Tissue Sample 2. (liver)	SRR015360(GSM380325) Plasma B cells (PC137). (B cell)	SRR107297(GSM677704) 18-30nt fraction of small RNA. (cell line)	GSM1105750AGO3(GSM1105750) small RNA sequencing data. (ago3 hela)	SRR444057(SRX128905) Sample 15cDNABarcode: AF-PP-334: ACG CTC TTC . (skin)	SRR330858(SRX091696) tissue: skin psoriatic involveddisease state:. (skin)	SRR330866(SRX091704) tissue: skin psoriatic involveddisease state:. (skin)	DRR000557(DRX000315) "THP-1 whole cell RNA, after 3 day treatment . (cell line)	TAX577588(Rovira) total RNA. (breast)	SRR039193(GSM494812) HL60 cell line is derived from acute promyelo. (cell line)	SRR330878(SRX091716) tissue: skin psoriatic involveddisease state:. (skin)	SRR033720(GSM497065) EBV activated B cell line (EBV159). (B cell)	SRR444058(SRX128906) Sample 16cDNABarcode: AF-PP-335: ACG CTC TTC . (skin)	DRR000562(DRX000320) Isolation of RNA following immunoprecipitatio. (ago3 cell line)	SRR039635(GSM518472) THP1_nuc_sRNAs. (cell line)	SRR330921(SRX091759) tissue: normal skindisease state: normal. (skin)	SRR039615(GSM531978) Severe Chronic Hepatitis B Liver Tissue. (liver)	SRR039625(GSM531988) HBV(-) HCV(-) HCC Tissue Sample. (liver)	TAX577741(Rovira) total RNA. (breast)	SRR342896(SRX096792) small RNA seq of Right atrial tissue. (heart)	SRR033719(GSM497064) 6hr Activated B cell line (ABC158). (B cell)	SRR330865(SRX091703) tissue: skin psoriatic involveddisease state:. (skin)	SRR330915(SRX091753) tissue: normal skindisease state: normal. (skin)	SRR330916(SRX091754) tissue: normal skindisease state: normal. (skin)	SRR191407(GSM715517) 81genomic small RNA (size selected RNA from t. (breast)	SRR326282(GSM769512) "Dicer mRNA was knocked down using siDicer, t. (cell line)	DRR000559(DRX000317) "THP-1 whole cell RNA, no treatment". (cell line)	SRR060985(GSM569189) Human naive B cell [09-001]. (cell line)	SRR039623(GSM531986) HCV(+) HCC Tissue Sample. (liver)	GSM450606(GSM450606) miRNA sequencing raw reads from post-mortem s. (brain)	SRR330895(SRX091733) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR330905(SRX091743) tissue: normal skindisease state: normal. (skin)	GSM1105748AGO1(GSM1105748) small RNA sequencing data. (ago1 hela)	SRR191613(GSM715723) 66genomic small RNA (size selected RNA from t. (breast)	GSM1105749AGO2(GSM1105749) small RNA sequencing data. (ago2 hela)	SRR033713(GSM497058) Burkitt Lymphoma (BL115). (B cell)	SRR037936(GSM510474) 293cand1. (cell line)	SRR553575(SRX182781) source: Kidney. (Kidney)	SRR330859(SRX091697) tissue: skin psoriatic involveddisease state:. (skin)	SRR553576(SRX182782) source: Testis. (testes)	SRR330873(SRX091711) tissue: skin psoriatic involveddisease state:. (skin)	SRR207111(GSM721073) Whole cell RNA. (cell line)	SRR363673(GSM830250) cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)	SRR189787	SRR342897(SRX096793) small RNA seq of Left atrial tissue. (heart)	SRR330908(SRX091746) tissue: normal skindisease state: normal. (skin)	GSM450604(GSM450604) miRNA sequencing raw reads from post-mortem s. (brain)	SRR553573(SRX182779) source: Cerebellum. (Cerebellum)	SRR330899(SRX091737) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR330902(SRX091740) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR330872(SRX091710) tissue: skin psoriatic involveddisease state:. (skin)
............................GGGAGAACAGGCTCGGATCTT.........................................................................................................................................................................................................	21	1.00	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
..........................................................................................................................GAGTTCTGGGATACTGTG..............................................................................................................	18	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-
.........................................................................................................................................................................................GAACTCATTCCCCAGTGAT..............................................	19	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-